Parkinson's disease Board decisions

All appeals were withdrawn by the Veteran's representative prior to the Board's decision, and therefore, the appeal is dismissed.

The Board remands the claim for additional development, including obtaining outstanding treatment records from various providers.

The Board remands the claim for a new VA examination to determine whether the Veteran has Parkinsonism or if there is a nexus between any 'Parkinson's-like' or 'Parkinsonism-like' symptoms and in-service herbicide exposure.

The Board denied service connection for Parkinson's disease, parkinsonism, and peripheral neuropathy in the upper and lower extremities as there was no evidence of exposure to herbicide agents during active service or sufficient evidence linking these conditions to service.

The Board granted service connection for the cause of the Veteran's death, finding that the Veteran's Wolff-Parkinson-White (WPW) condition and subsequent arrhythmias contributed to his congestive heart failure.

The Board remands the claims for service connection for hypertension, ischemic heart disease, parkinsonism (also claimed as tremors), and shortness of breath to correct a pre-decisional duty to assist error related to verifying the Veteran's claimed herbicide agent exposure in Okinawa.

The Board remands the claims for service connection due to a need for further adjudication by the AOJ in light of new evidence.

The Board denied service connection for an acquired psychiatric disability, a neurological disability (claimed as Parkinson's disease), and a cardiovascular disability due to lack of evidence linking these conditions to the Veteran's military service or exposure to contaminated water at Camp Lejeune.

The appeal for service connection for primary progressive aphasia (PPA) was dismissed due to the Veteran's death during the pendency of the appeal.

The Board denied service connection for coronary artery disease, diabetes mellitus type II, Parkinson's disease, peripheral neuropathy in both upper and lower extremities, and non-Hodgkin's lymphoma as there was no evidence of chronic conditions during service or within the applicable presumptive period, continuity of symptomatology, or a causal relationship to an in-service injury or disease.

The Board granted an effective date of February 5, 2021, for the award of service connection for Parkinsonism and its manifestations.

The appeal was dismissed due to the Veteran's August 2024 VA Form 10182 not being in conformity with the requirements for an appealable rating decision.

The Board granted service connection for coronary artery disease, Parkinson's disease, and hypertension based on the Veteran's exposure to herbicide agents during his service in the Republic of Vietnam.

The Board granted service connection for Parkinson's disease due to presumed exposure to herbicide agents during the Veteran's service in Korea. The claims for peripheral neuropathy were remanded for further evidence.

The Board remands the claim for service connection for Parkinson's Disease to obtain a medical opinion regarding its etiology, considering potential exposure to Agent Orange outside the presumptive period.

The Board denied the Veteran's appeal for an earlier effective date for service connection for Parkinson's disease and special monthly compensation (SMC) at the housebound rate, as there is no evidence of a formal or informal claim prior to June 17, 2021, and he was not service-connected for any disability prior to that date.

The Board remands the claim for a disease manifested by tremors, to include Parkinson's disease, for an examination and further development.

The Board remands the case to obtain additional evidence and a medical opinion regarding the Veteran's Parkinson's disease.

The Board denied the claims for service connection for Parkinson's disease, hypertension, and a cardiovascular disability, as well as entitlement to service connection for the Veteran's cause of death and Dependency and Indemnity Compensation (DIC) under 38 U.S.C. §1318.

The appeal for a compensable evaluation for erectile dysfunction was dismissed, and the Veteran's Parkinson's disease with cognitive impairment, depression, and sleep disturbances is rated at 30 percent. Various other claims were remanded.